No Data
No Data
No Data
No Data
No Data
ITeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity From Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024
iTeos Therapeutics, Inc. (NASDAQ:ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced a poster presentation of preclinical data on EOS-984
Globe NewswireApr 7 16:30 ET
Analysts Offer Insights on Healthcare Companies: ITeos Therapeutics (ITOS), Rani Therapeutics Holdings (RANI) and Vor Biopharma (VOR)
TipRanksMar 21 07:30 ET
Top Premarket Decliners
SurgePays (SURG) shares slumped 22% Wednesday premarket after the company reported lower Q4 revenue. Latham Group (SWIM) shares dropped 18% after the company reported lower Q4 sales. Bit Origin (BTOG)
MT NewswiresMar 13 08:03 ET
ITeos Therapeutics Is Maintained at Overweight by JP Morgan
ITeos Therapeutics Is Maintained at Overweight by JP Morgan
Dow JonesMar 12 09:20 ET
Express News | JP Morgan Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $27
Moomoo 24/7Mar 12 09:09 ET
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), AnaptysBio (ANAB) and ITeos Therapeutics (ITOS)
TipRanksMar 12 06:40 ET
Theinvestor : This Stock will xplode big,stay long.!!!!!!!!!!!!!!!!!!!
Theinvestor Theinvestor: DDOG
No Data
No Data